Epic Corp. Share Price

EPOR

US29428L4032

Blockchain & Cryptocurrency

Market Closed - OTC Markets Other stock markets 15:24:07 19/04/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2022	Sanofi profit gain beats market view on bestseller drug Dupixent	RE
2022	Sanofi to float drug ingredients manufacturing business on May 6	RE

News in other languages on Epic Corp.

Le bénéfice de Sanofi dépasse les attentes au 1er trimestre grâce au Dupixent	28/04/22
Le bénéfice de Sanofi dépasse les attentes au T1 grâce au Dupixent	28/04/22
Planète Bourse : La revue de presse du mardi 16 novembre 2021	16/11/21
++ Analysen des Tages von Dow Jones Newswires (13.09.2021) +++	13/09/21
ANALYSE/Apples "Gartenmauer" bekommt Risse	13/09/21

More news

Highs and lows

1 year

0.00

3 years

0.00

0.41

5 years

0.00

0.70

10 years

0.00

4.89

More quotes

Managers and Directors - Epic Corp.

Managers	Title	Age	Since
Ronald S. Tucker CEO	Chief Executive Officer	84	30/09/97

Members of the board	Title	Age	Since
Ronald S. Tucker CEO	Chief Executive Officer	84	30/09/97

More insiders

EPIC Corporation was engaged in developing and implementing the EPIC monetary system. Its EPIC monetary system included virtual money system called EPIC digital dollars. The Company has ceased all its business operations and has no plans to seek business opportunities.

Sector

Blockchain & Cryptocurrency

More about the company

Sector Blockchain & Cryptocurrency (NEC)

	1st Jan change	Capi.
EPIC CORP.	-.--%	20
COINBASE GLOBAL, INC.	+15.52%	49.34B
GRAYSCALE ETHEREUM TRUST	+7.00%	6.45B
OSL GROUP LIMITED	-44.57%	540M
GRAYSCALE LITECOIN TRUST	+63.49%	509M
GRAYSCALE BITCOIN CASH TRUST	+160.97%	428M
ATHENA BITCOIN GLOBAL	-47.24%	367M
KARBON-X CORP.	-.--%	118M
WONDERFI TECHNOLOGIES INC.	-27.12%	103M
CRYPTO-BLOCKCHAIN INDUSTRIES, SA	-15.56%	102M

Blockchain & Cryptocurrency (NEC)

Sales 2008	22.12K 1.77M	Sales 2009	5.22K 417K	Capitalization	563K 44.97M
Net income 2008	- 0	Net income 2009	- 0	EV / Sales 2008	33.3 x
Net Debt 2008	399K 31.9M	Net Debt 2009	673K 53.78M	EV / Sales 2009	237 x
P/E ratio 2008	-0.98 x	P/E ratio 2009	-1.34 x	Employees	2
Yield 2008 *	-	Yield 2009	-	Free-Float	100%

Sanofi profit gain beats market view on bestseller drug Dupixent	28/04/22	RE
Sanofi to float drug ingredients manufacturing business on May 6	01/04/22	RE
Apple, Epic Antitrust Ruling Issued by US Judge: Bloomberg	10/09/21	MT
Apple Inc. : Is it really the end of the Apple supercycle?	22/06/21
Epic Corporation Announces Updates on Disruptive Cryptocurrency	15/04/19	CI
Epic To Seek Acquisitions	15/04/19	CI
Epic Presents the Epic Monetary System	18/03/19	CI
EPIC Corporation Announces the Resignation of James G. Xilas as Officer and Director	04/03/19	CI
Epic Corp. Reports Earnings Results for the Year Ended September 30, 2015	05/01/16	CI
Epic Corp. announced that it expects to receive $2 million in funding.	22/09/15	CI
EPIC Corporation Inc. Introduces AcuFAB (R) Acupressure Insoles	24/11/14	CI
EPIC Corporation Inc. Receives One Time License Fee of $1 Million from Epic's Medicor Corporation	19/11/14	CI
Epic Corp. acquired EPIC Fabric Healthcare Products.	17/11/14	CI
Epic Corporation to Form Joint Venture with Salem Sleep Systems, Inc	13/08/14	CI
Epic Corp. Announces Earnings Results for the Year Ended September 30, 2013	31/10/13	CI

Epic Corp. Share Price

Equities

EPOR

US29428L4032

Blockchain & Cryptocurrency

Financials

Chart Epic Corp.

Latest news about Epic Corp.